In conclusion, by uncovering multiple mechanisms, including apoptosis, autophagy, and PI3K/Akt pathway inhibition, this study expands the pharmacological profile of PA into osteosarcoma for the first time, underscoring its novelty and clinical relevance. Here, AKT1 is linked to osteosarcoma.